Arginine or Hypertonic Saline.Stimulated Copeptin to Diagnose AVP Deficiency

Julie Refardt*, Cihan Atila, Irina Chifu, Emanuele Ferrante, Zoran Erlic, Juliana B. Drummond, Rita Indirli, Roosmarijn C. Drexhage, Clara O. Sailer, Andrea Widmer, Susan Felder, Andrew S. Powlson, Nina Hutter, Mark Gurnell, Beatriz S. Soares, Johannes Hofland, Felix Beuschlein, Martin Fassnacht, Bettina Winzeler, Mirjam Christ-Crain

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)

Abstract

Background: 

Distinguishing between arginine vasopressin (AVP) deficiency and primary polydipsia is challenging. Hypertonic saline'stimulated copeptin has been used to diagnose AVP deficiency with high accuracy but requires close sodium monitoring. Arginine-stimulated copeptin has shown similar diagnostic accuracy but with a simpler test protocol. However, data are lacking from a head-to-head comparison between arginine-stimulated copeptin and hypertonic saline'stimulated copeptin in the diagnosis of AVP deficiency. 

Methods: 

In this international, noninferiority trial, we assigned adult patients with polydipsia and hypotonic polyuria or a known diagnosis of AVP deficiency to undergo diagnostic evaluation with hypertonic-saline stimulation on one day and with arginine stimulation on another day. Two endocrinologists independently made the final diagnosis of AVP deficiency or primary polydipsia with use of clinical information, treatment response, and the hypertonic-saline test results. The primary outcome was the overall diagnostic accuracy according to prespecified copeptin cutoff values of 3.8 pmol per liter after 60 minutes for arginine and 4.9 pmol per liter once the sodium level was more than 149 mmol per liter for hypertonic saline. 

Results: 

Of the 158 patients who underwent the two tests, 69 (44%) received the diagnosis of AVP deficiency and 89 (56%) received the diagnosis of primary polydipsia. The diagnostic accuracy was 74.4% (95% confidence interval [CI], 67.0 to 80.6) for arginine-stimulated copeptin and 95.6% (95% CI, 91.1 to 97.8) for hypertonic saline-stimulated copeptin (estimated difference, -21.2 percentage points; 95% CI, -28.7 to -14.3). Adverse events were generally mild with the two tests. A total of 72% of the patients preferred testing with arginine as compared with hypertonic saline. Arginine-stimulated copeptin at a value of 3.0 pmol per liter or less led to a diagnosis of AVP deficiency with a specificity of 90.9% (95% CI, 81.7 to 95.7), whereas levels of more than 5.2 pmol per liter led to a diagnosis of primary polydipsia with a specificity of 91.4% (95% CI, 83.7 to 95.6). 

Conclusions: 

Among adult patients with polyuria polydipsia syndrome, AVP deficiency was more accurately diagnosed with hypertonic saline'stimulated copeptin than with argininestimulated copeptin.

Original languageEnglish
Pages (from-to)1877-1887
Number of pages11
JournalNew England Journal of Medicine
Volume389
Issue number20
DOIs
Publication statusPublished - 16 Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 Massachussetts Medical Society. All rights reserved.

Fingerprint

Dive into the research topics of 'Arginine or Hypertonic Saline.Stimulated Copeptin to Diagnose AVP Deficiency'. Together they form a unique fingerprint.

Cite this